Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature (NCT07386340)
🩺 Plain-English Summary (8th-Grade Level)
A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation is to evaluate the accuracy of the Gemini System with new technological flash glucose monitoring (FGM) feature enhancements compared to reference glucose measurements and the Eversense 365 CGM System. The investigation will also evaluate safety of the Gemini System usage.
Who can join: Review the eligibility criteria below.
Location: Headlands Research - AMCR Institute — Escondido, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Headlands Research - AMCR Institute — Escondido, California
📞 Contact the Study Coordinator
Phone: (667) 218-3309
Email: maggie.lewis@senseonics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus
- The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes — Boston, Massachusetts
- Oral Anti Diabetic Agents in the Hospital — Atlanta, Georgia
- Full Plate Living Nutrition Education Program — Madison, Wisconsin
- Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes — San Francisco, California
- Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes — Cleveland, Ohio
- Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years — Charlestown, Massachusetts
Explore by condition: All Diabetes Mellitus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.